FDA warns of MI, death risk with regadenoson, adenosine

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2013年 / 1481卷 / 1期

关键词：

D O I：

10.1007/s40278-013-7556-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[41] FDA warns of liver disorders with kavain
[J]. Reactions Weekly, 2002, 896 (1) : 2 - 2
[42] FDA WARNS LARGEST INDIAN DRUGMAKER
Venkatasubramanian, K. V.
[J]. CHEMICAL & ENGINEERING NEWS, 2016, 94 (01) : 16 - 16
[43] Risk of MI and death with NSAIDs in healthy individuals
[J]. Reactions Weekly, 2009, 1245 (1) : 3 - 3
[44] FDA warns against colloidal silver
不详
[J]. LARGE ANIMAL PRACTICE, 1997, 18 (03): : 8 - 8
[45] FDA warns of clopidogrel/omeprazole interaction
[J]. Reactions Weekly, 2009, 1279 (1) : 1 - 1
[46] THE DEATH OF A SIGNIFICANT PERSON INCREASES MI RISK
Rosenberg, Karen
[J]. AMERICAN JOURNAL OF NURSING, 2012, 112 (06) : 53 - 53
[47] Sildenafil: no increased risk of death due to MI
[J]. Reactions Weekly, 2002, 909 (1) : 4 - 4
[48] FDA warns that compounding clenbuterol is illegal
不详
[J]. JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2002, 220 (04) : 442 - 443
[49] FDA warns of reactions to midline catheters
Choo, V
[J]. LANCET, 1996, 347 (8999): : 458 - 458
[50] FDA warns Micotil 300 is dangerous
Cima, Greg
[J]. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2017, 251 (10): : 1113 - 1113

← 1 2 3 4 5 →